RxDoctor Payments Data

Sean Clinefelter, MD

Interventional Pain Medicine · North Kansas City, MONPI 1447332168

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 257 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 73.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $860 and has fallen 84.8% since, to $130 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MO, where the typical reported total is $2,673.

$2,399in general payments, 2019–2025

Across 257 payments — averaging $9.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • SPR Therapeutics, Inc$212
  • Boston Scientific$169
  • Nevro Corp.$130
  • Relievant Medsystems, Inc.$119
  • Vertos Medical, Inc.$6

What the payments were for

  • Travel & lodging$372%
  • Food & beverage$2,36198%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,399 in reported general payments places this provider in the 45th percentile of 27 interventional pain medicine providers in Missouri.

See all interventional pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$241,549
Medicare patients
517
Services billed
1,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen654$15,737
OxycontinOxycodone Hcl19$7,376
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen269$6,541
Xtampza ErOxycodone Myristate12$6,490
Oxycodone Hcl137$3,410
Pregabalin119$2,782
Morphine Sulfate ErMorphine Sulfate74$1,976
Gabapentin90$1,577
Tramadol Hcl282$1,405
Morphine Sulfate18$499
Baclofen29$461
Cyclobenzaprine Hcl14$207
Tizanidine Hcl19$117
Meloxicam12$45
Diazepam13$8

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →